Title |
Rheum officinale (a traditional Chinese medicine) for chronic kidney disease
|
---|---|
Published in |
Cochrane database of systematic reviews, July 2012
|
DOI | 10.1002/14651858.cd008000.pub2 |
Pubmed ID | |
Authors |
Han Wang, Hongxian Song, Jirong Yue, Jun Li, Yan Bin Hou, Jue Lin Deng |
Abstract |
Chronic kidney disease (CKD) is a major public health issue worldwide. Standard therapies to delay CKD progression include dietary protein restriction and administration of angiotensin-converting enzyme inhibitors (ACEi) and angiotensin receptor blockers (ARB) to help control blood pressure and confer additional renoprotective effects. Despite such interventions, CKD incidence and mortality rates continue to increase. Rheum officinale (Da Huang) a medicinal herb used widely in China to treat CKD has been reported to offer a range of pharmacological properties that may delay disease progression. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 156 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Australia | 1 | <1% |
Unknown | 155 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 22 | 14% |
Student > Ph. D. Student | 17 | 11% |
Researcher | 16 | 10% |
Student > Bachelor | 12 | 8% |
Student > Doctoral Student | 10 | 6% |
Other | 27 | 17% |
Unknown | 52 | 33% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 51 | 33% |
Nursing and Health Professions | 7 | 4% |
Pharmacology, Toxicology and Pharmaceutical Science | 7 | 4% |
Psychology | 7 | 4% |
Economics, Econometrics and Finance | 5 | 3% |
Other | 20 | 13% |
Unknown | 59 | 38% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 August 2012.
All research outputs
#20,723,696
of 25,457,858 outputs
Outputs from Cochrane database of systematic reviews
#10,914
of 11,499 outputs
Outputs of similar age
#139,661
of 178,136 outputs
Outputs of similar age from Cochrane database of systematic reviews
#162
of 178 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 178,136 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 9th percentile – i.e., 9% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 178 others from the same source and published within six weeks on either side of this one. This one is in the 3rd percentile – i.e., 3% of its contemporaries scored the same or lower than it.